Matchpoint Therapeutics
PrivateLast Round
Corporate Funding
Jul 24, 2025
Total Funding Raised
$130M
Company Overview
Matchpoint Therapeutics is a biotechnology company that develops precision small molecule medicines leveraging covalency to treat immune diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Matchpoint Therapeutics Comparables
Compare Matchpoint Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Totus Medicines | 86% | |
| Enlaza Therapeutics | 79% | |
| Dunad Therapeutics | 77% | |
Matchpoint Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Corporate Funding | Jul 24, 2025 | ||||
| Series A | Oct 14, 2022 | ||||
| Seed | Nov 30, 2021 | ||||
| Seed | Nov 1, 2021 |
Matchpoint Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Access Industries | Seed |
| Vertex Ventures HC | Series A |
| Digitalis Ventures | Series A |
| Alexandria Venture Investments | Series A |
| Sanofi Ventures | Series A |
| Atlas Venture | Series A, Seed |
| Access Biotechnology | Series A, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2025
$60M raised in corporate funding.
- Jul 24, 2025
Exclusive option and license deal with Novartis for inflammatory disease inhibitors.
Matchpoint Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Matchpoint Therapeutics's valuation, stock price, and market status.